On Friday's news that Biohaven (BHVN -15.34%) withdrew its application for a top investigational drug from an important ...

Bengaluru: Biocon Biologics Ltd, a fully integrated global biosimilars company and subsidiary of Biocon Ltd, has announced ...

Key treatments for Alzheimer’s, rare cancers, and infectious diseases are under review, with new vaccines and therapies like ...

RBC Capital after notes released by the European Medicines Agency’s CHMP indicated that Biohaven (BHVN) had withdrawn the application for ...

Patients are losing out on life-changing drugs for cancer and rare diseases because of Brexit, experts have warned.

Biohaven (BHVN) withdrew the initial marketing authorization application for troriluzole, the European Medicines Agency posted on its ...

Hyderabad: CuraTeQ Biologics s.r.o., a wholly owned step-down subsidiary of Aurobindo Pharma Limited, has announced that the Committee for Medicinal Products for Human Use (CHMP) of the ...

Dyne anticipates filing a Biologics License Application (BLA) submission for US accelerated approval in early 2026.